See more : GPX Medical AB (publ) (GPXMED.ST) Income Statement Analysis – Financial Results
Complete financial analysis of Apollo Hospitals Enterprise Limited (APOLLOHOSP.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Apollo Hospitals Enterprise Limited, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Ameriwest Lithium Inc. (AWLIF) Income Statement Analysis – Financial Results
- kaonavi, inc. (4435.T) Income Statement Analysis – Financial Results
- Sheng Siong Group Ltd (OV8.SI) Income Statement Analysis – Financial Results
- Cellectis S.A. (CLLS) Income Statement Analysis – Financial Results
- Gold and GemStone Mining Inc. (GGSM) Income Statement Analysis – Financial Results
Apollo Hospitals Enterprise Limited (APOLLOHOSP.BO)
About Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited, together with its subsidiaries, provides healthcare services in India and internationally. It operates through Healthcare Services, Retail Health & Diagnostics, Digital Health & Pharmacy Distribution, and Others segments. The company's healthcare facilities comprise primary, secondary, and tertiary care facilities. It offers services in cardiac sciences, orthopedics, oncology, neurosciences, emergency, robotic surgery, and transplants; and cardiology, neurology, gastroenterology, dermatology, ophthalmology, pediatric, endocrinology, gynecology, urology, nephrology, pulmonology, rheumatology, neurosurgery, radiology, plastic-surgery, neonatology, vascular-surgery, psychiatry, dentistry, ear, nose, and throat care services. The company also provides other services, such as project consultancy, health insurance, medical colleges, medvarsity for e-learning, and research services. In addition, it operates pharmacies, primary care clinics, birthing centers, specialized birthing centers, dialysis centers, cradle and fertility centers, diabetes management centers, single specialty clinics, primary health centers and diagnostic chains, dental clinics, and daycare and home healthcare centers. Further, the company engages in the business of bio-banking of tissues. The company serves through national retail healthcare centers and genomics institutes, as well as Apollo 24/7, a digital health platform; and www.apollopharmacy.in, an online pharmacy. Apollo Hospitals Enterprise Limited was incorporated in 1979 and is based in Chennai, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 190.59B | 164.45B | 145.36B | 104.68B | 111.47B | 95.94B | 82.23B | 72.32B | 62.15B | 51.78B | 43.84B | 37.69B | 31.48B | 26.05B | 20.26B | 16.14B | 12.16B | 9.49B | 7.60B | 6.61B |
| Cost of Revenue | 98.06B | 85.74B | 75.74B | 56.84B | 54.99B | 46.61B | 40.33B | 35.99B | 30.55B | 25.81B | 21.50B | 18.56B | 15.62B | 13.18B | 10.73B | 8.73B | 6.53B | 5.10B | 4.09B | 3.33B |
| Gross Profit | 92.54B | 78.71B | 69.63B | 47.84B | 56.48B | 49.33B | 41.91B | 36.33B | 31.60B | 25.97B | 22.34B | 19.13B | 15.85B | 12.87B | 9.54B | 7.41B | 5.63B | 4.40B | 3.51B | 3.28B |
| Gross Profit Ratio | 48.55% | 47.86% | 47.90% | 45.70% | 50.67% | 51.42% | 50.96% | 50.23% | 50.85% | 50.16% | 50.96% | 50.76% | 50.36% | 49.41% | 47.07% | 45.93% | 46.32% | 46.30% | 46.18% | 49.64% |
| Research & Development | 234.00M | 211.00M | 110.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 18.95B | 14.93B | 12.19B | 7.18B | 8.05B | 7.38B | 6.10B | 5.06B | 1.13B | 643.88M | 511.67M | 500.24M | 435.14M | 1.99B | 3.22B | 1.73B | 1.29B | 1.04B | 115.37M | 95.50M |
| Selling & Marketing | 6.58B | 6.40B | 3.65B | 2.00B | 2.27B | 1.84B | 1.74B | 1.32B | 1.57B | 932.10M | 793.94M | 832.69M | 601.81M | 656.95M | 378.55M | 427.43M | 325.30M | 229.75M | 99.34M | 84.25M |
| SG&A | 25.53B | 21.33B | 15.84B | 9.18B | 10.32B | 9.22B | 7.84B | 6.38B | 2.70B | 1.58B | 1.31B | 1.33B | 1.04B | 2.65B | 3.22B | 2.15B | 1.62B | 1.27B | 214.71M | 179.75M |
| Other Expenses | 65.04B | 171.00M | 172.00M | 185.00M | 110.00M | 89.00M | 118.19M | 20.23M | 112.30M | 13.96M | 17.73M | 301.74M | 259.07M | -1.87M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 90.57B | 64.21B | 53.74B | 42.17B | 46.13B | 42.59B | 37.37B | 31.95B | 27.06B | 20.45B | 17.08B | 14.30B | 11.79B | 9.03B | 5.58B | 5.59B | 4.05B | 3.49B | 2.49B | 2.40B |
| Cost & Expenses | 173.35B | 149.96B | 129.48B | 99.01B | 101.12B | 89.20B | 77.70B | 67.94B | 57.60B | 46.26B | 38.58B | 32.86B | 27.41B | 22.21B | 16.31B | 14.32B | 10.58B | 8.59B | 6.58B | 5.73B |
| Interest Income | 429.00M | 444.00M | 351.00M | 218.00M | 173.00M | 145.00M | 184.47M | 122.67M | 80.52M | 34.00M | 45.20M | 911.19M | 132.16M | 100.25M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 4.49B | 3.14B | 3.30B | 4.06B | 4.63B | 2.84B | 2.59B | 2.28B | 1.62B | 925.37M | 959.33M | 0.00 | 675.52M | 778.47M | 602.06M | 458.79M | 382.11M | 270.07M | 243.59M | 242.44M |
| Depreciation & Amortization | 6.86B | 6.15B | 6.00B | 5.73B | 6.19B | 3.95B | 3.58B | 3.13B | 2.66B | 2.12B | 1.67B | 1.42B | 1.24B | 941.70M | 749.51M | 632.17M | 516.75M | 407.54M | 378.34M | 311.31M |
| EBITDA | 24.02B | 21.39B | 25.57B | 12.42B | 18.12B | 10.95B | 8.25B | 7.65B | 7.60B | 7.38B | 6.78B | 6.31B | 5.35B | 4.34B | 3.33B | 2.43B | 2.09B | 1.90B | 1.30B | 1.19B |
| EBITDA Ratio | 12.60% | 12.52% | 15.09% | 10.82% | 13.86% | 10.94% | 9.80% | 11.06% | 12.30% | 14.40% | 15.47% | 16.73% | 16.99% | 16.75% | 16.42% | 15.19% | 17.22% | 20.09% | 17.51% | 17.96% |
| Operating Income | 17.07B | 14.64B | 16.07B | 5.92B | 9.83B | 6.86B | 4.52B | 4.30B | 4.39B | 5.34B | 5.11B | 4.89B | 4.11B | 3.42B | 2.58B | 1.82B | 1.58B | 1.50B | 951.80M | 875.18M |
| Operating Income Ratio | 8.96% | 8.90% | 11.06% | 5.66% | 8.82% | 7.15% | 5.49% | 5.94% | 7.07% | 10.32% | 11.66% | 12.96% | 13.07% | 13.14% | 12.72% | 11.27% | 12.97% | 15.80% | 12.53% | 13.25% |
| Total Other Income/Expenses | -3.45B | -3.21B | -30.75B | -3.72B | -3.75B | -3.02B | -2.82B | -2.16B | -1.22B | -972.97M | -1.19B | -838.20M | -806.25M | -810.00M | -602.06M | -475.56M | -393.44M | -275.25M | -278.44M | -347.48M |
| Income Before Tax | 13.63B | 11.44B | 15.78B | 2.21B | 6.60B | 3.73B | 1.71B | 2.22B | 3.32B | 4.55B | 4.07B | 3.99B | 3.26B | 2.61B | 1.98B | 1.34B | 1.19B | 1.22B | 673.36M | 527.63M |
| Income Before Tax Ratio | 7.15% | 6.95% | 10.86% | 2.11% | 5.92% | 3.88% | 2.09% | 3.07% | 5.34% | 8.79% | 9.28% | 10.59% | 10.36% | 10.03% | 9.75% | 8.32% | 9.78% | 12.90% | 8.86% | 7.99% |
| Income Tax Expense | 4.46B | 2.56B | 4.77B | 847.00M | 2.25B | 1.73B | 1.12B | 909.59M | 968.96M | 1.30B | 1.02B | 1.05B | 1.15B | 872.95M | 675.86M | 489.94M | 374.12M | 325.58M | 238.40M | 203.65M |
| Net Income | 8.99B | 8.19B | 10.56B | 1.50B | 4.55B | 2.36B | 1.17B | 2.21B | 2.36B | 3.31B | 3.06B | 2.96B | 2.12B | 1.76B | 1.34B | 909.70M | 854.45M | 898.69M | 481.37M | 356.31M |
| Net Income Ratio | 4.71% | 4.98% | 7.26% | 1.44% | 4.08% | 2.46% | 1.43% | 3.06% | 3.80% | 6.38% | 6.99% | 7.85% | 6.74% | 6.74% | 6.60% | 5.64% | 7.02% | 9.47% | 6.34% | 5.39% |
| EPS | 62.50 | 56.97 | 73.42 | 10.74 | 32.69 | 16.96 | 8.44 | 15.88 | 16.99 | 24.43 | 22.77 | 22.08 | 16.83 | 14.84 | 11.15 | 8.60 | 7.05 | 9.36 | 5.41 | 4.73 |
| EPS Diluted | 62.50 | 56.97 | 73.42 | 10.74 | 32.69 | 16.96 | 8.44 | 15.88 | 16.99 | 24.43 | 22.77 | 21.88 | 16.30 | 14.37 | 11.10 | 8.30 | 6.77 | 9.21 | 5.30 | 4.73 |
| Weighted Avg Shares Out | 143.78M | 143.78M | 143.78M | 139.99M | 139.13M | 139.13M | 139.13M | 139.13M | 139.13M | 139.13M | 139.13M | 137.84M | 130.33M | 123.92M | 123.43M | 119.26M | 109.34M | 101.94M | 96.12M | 81.19M |
| Weighted Avg Shares Out (Dil) | 143.78M | 143.78M | 143.78M | 139.99M | 139.13M | 139.13M | 139.13M | 139.13M | 139.13M | 139.13M | 139.13M | 139.13M | 134.87M | 128.00M | 123.96M | 123.57M | 113.83M | 103.59M | 98.20M | 81.19M |
Source: https://incomestatements.info
Category: Stock Reports